Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/30/26 17:49 | 6/26/26 | IRON | Health | Drug | Pharmaceutical Preparations | Khara Rahul | MA | O | GC | 4 | M.dm | 861 | 43.05 | 0 | 20 | 62 | 52 | D | ||||||||||||||
6/30/26 17:49 | 6/26/26 | IRON | Health | Drug | Pharmaceutical Preparations | Khara Rahul | MA | O | GC | 4 | S.dm | -861 | 43.05 | 0 | -20 | 52 | D | |||||||||||||||
6/30/26 17:45 | 6/26/26 | IRON | Health | Drug | Pharmaceutical Preparations | Yu Jonathan Yen-Wen | MA | O | COO | 6 | M.d | 2,333 | 40.77 | 0 | 57 | 54 | D | |||||||||||||||
6/30/26 17:45 | 6/26/26 | IRON | Health | Drug | Pharmaceutical Preparations | Yu Jonathan Yen-Wen | MA | O | COO | 6 | S.d | -2,333 | 40.77 | 0 | -57 | 54 | D | |||||||||||||||
6/23/26 17:16 | 6/18/26 | IRON | Health | Drug | Pharmaceutical Preparations | Quisel John D | MA | DO | CEO | 2 | M.d | 2,723 | 40.04 | 0 | 68 | 43 | 226 | D | ||||||||||||||
6/23/26 17:16 | 6/18/26 | IRON | Health | Drug | Pharmaceutical Preparations | Quisel John D | MA | DO | CEO | 2 | S.d | -2,723 | 40.04 | 0 | -68 | 226 | D | |||||||||||||||
4/15/26 17:05 | 4/13/26 | IRON | Health | Drug | Pharmaceutical Preparations | Savage William Jacob | MA | O | Chief Me | 1 | S | -380 | 66.38 | 0 | -6 | 79 | D | |||||||||||||||
4/15/26 16:53 | 4/13/26 | IRON | Health | Drug | Pharmaceutical Preparations | Franchi Jean M. | MA | O | CFO | 1 | S.m | -461 | 69.23 | 0 | -7 | 64 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |